252 related articles for article (PubMed ID: 26712102)
1. Risk Prediction Models for Lung Cancer: A Systematic Review.
Gray EP; Teare MD; Stevens J; Archer R
Clin Lung Cancer; 2016 Mar; 17(2):95-106. PubMed ID: 26712102
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Ten Haaf K; Jeon J; Tammemägi MC; Han SS; Kong CY; Plevritis SK; Feuer EJ; de Koning HJ; Steyerberg EW; Meza R
PLoS Med; 2017 Apr; 14(4):e1002277. PubMed ID: 28376113
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.
Lu MT; Raghu VK; Mayrhofer T; Aerts HJWL; Hoffmann U
Ann Intern Med; 2020 Nov; 173(9):704-713. PubMed ID: 32866413
[TBL] [Abstract][Full Text] [Related]
4. Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
Katki HA; Kovalchik SA; Petito LC; Cheung LC; Jacobs E; Jemal A; Berg CD; Chaturvedi AK
Ann Intern Med; 2018 Jul; 169(1):10-19. PubMed ID: 29800127
[TBL] [Abstract][Full Text] [Related]
5. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract][Full Text] [Related]
6. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
[TBL] [Abstract][Full Text] [Related]
7. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO
Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K
Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer.
Choi E; Sanyal N; Ding VY; Gardner RM; Aredo JV; Lee J; Wu JT; Hickey TP; Barrett B; Riley TL; Wilkens LR; Leung AN; Le Marchand L; Tammemägi MC; Hung RJ; Amos CI; Freedman ND; Cheng I; Wakelee HA; Han SS
J Natl Cancer Inst; 2022 Jan; 114(1):87-96. PubMed ID: 34255071
[TBL] [Abstract][Full Text] [Related]
9. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
[TBL] [Abstract][Full Text] [Related]
10. Population risk prediction models for incident heart failure: a systematic review.
Echouffo-Tcheugui JB; Greene SJ; Papadimitriou L; Zannad F; Yancy CW; Gheorghiade M; Butler J
Circ Heart Fail; 2015 May; 8(3):438-47. PubMed ID: 25737496
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the accuracy of the PLCO
Jantzen R; Ezer N; Camilleri-Broët S; Tammemägi MC; Broët P
CMAJ Open; 2023; 11(2):E314-E322. PubMed ID: 37041013
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
[TBL] [Abstract][Full Text] [Related]
13. Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment.
Fahrmann JF; Marsh T; Irajizad E; Patel N; Murage E; Vykoukal J; Dennison JB; Do KA; Ostrin E; Spitz MR; Lam S; Shete S; Meza R; Tammemägi MC; Feng Z; Hanash SM
J Clin Oncol; 2022 Mar; 40(8):876-883. PubMed ID: 34995129
[TBL] [Abstract][Full Text] [Related]
14. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.
Raji OY; Duffy SW; Agbaje OF; Baker SG; Christiani DC; Cassidy A; Field JK
Ann Intern Med; 2012 Aug; 157(4):242-50. PubMed ID: 22910935
[TBL] [Abstract][Full Text] [Related]
15. Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
Bravo-Iñiguez CE; Fox SW; De Leon LE; Tarascio JN; Jaklitsch MT; Jacobson FL
J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1248-1254.e1. PubMed ID: 31248631
[TBL] [Abstract][Full Text] [Related]
16. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.
Al-Rubaie Z; Askie LM; Ray JG; Hudson HM; Lord SJ
BJOG; 2016 Aug; 123(9):1441-52. PubMed ID: 27225348
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.
Ten Haaf K; Bastani M; Cao P; Jeon J; Toumazis I; Han SS; Plevritis SK; Blom EF; Kong CY; Tammemägi MC; Feuer EJ; Meza R; de Koning HJ
J Natl Cancer Inst; 2020 May; 112(5):466-479. PubMed ID: 31566216
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
